top of page

Spotlight: Health Care Sector

Despite the volatility in the indices today, there was one sector that’s steady bid caught my eye: Health Care. I wanted to take a few minutes to dive into a couple of names within the sector that I’m interested in. If you haven’t had a chance to read Mayhems “Full Cycle Trading and Investing” blog post, I’d recommend checking it out here: https://www.traderade.com/post/full-cycle-trading-and-investing. I really enjoyed his post and it reminded me that it’s probably time to keep a closer watch on some health care names considering it’s entirely possible 2022 may present a threat to the raging bull market we’ve come accustomed to. As a retail investor, I’m actually excited for the prospect of some legitimate sector rotations. Tech and high risk assets have been the name of the game for a long time, but if there’s a chance they’ll be moving out of the spotlight then it’s worth a closer look at health care. Over the past year, most of the attention on this sector has been understandably skewed to a small handful of Covid vaccine related names, i.e. Moderna, Johnson & Johnson, and Pfizer (The latter 2 happen to be the #1 and #3 biggest names by weight, respectively, in the popular XLV Health Care Select Fund). Despite the success of a few names, XLV still looks healthy and poised for further upside:

Want to read more?

Subscribe to traderade.com to keep reading this exclusive post.

 
 
 

Sign Up and
Stay Updated

Person Analyzing Graphs On Screen

Disclaimer

Information contained in this website should not be construed as investment or trading advice. Opinions expressed herein by Traderade are not investment recommendations and are not meant to be relied upon in investment decisions. The Traderade.com website is not acting in an investment adviser capacity and neither are any authors on this website. Information presented is not an investment research report. Opinions expressed herein may address only select aspects of the companies mentioned and cannot be a substitute for comprehensive investment analysis.
 

Any analysis presented herein is illustrative in nature, limited in scope, based on an incomplete set of information, and has limitations to its accuracy. We recommend that potential and existing investors conduct thorough investment research of their own and consult a qualified investment adviser. The information upon which this material is based was obtained from sources believed to be reliable but has not been independently verified. Therefore we cannot guarantee its accuracy. Any opinions or estimates constitute our best judgment as of the date of publication and are subject to change without notice.
 

The authors may buy or sell shares without any further notice and may have a position in any shares of any of the companies or asset classes mentioned. By using this website you agree with our full Terms of Use and Privacy Policy.

Navigation

Copyright 2025 Traderade. All rights reserved.

  • Twitter
  • Youtube
bottom of page